ITI Pharma and Healthcare Fund - Direct - Growth
A Equity Scheme by ITI Asset Management Limited
3Y Returns (CAGR)
20.53%
Expense Ratio
0.47%
as of 01/03/2026
AUM
₹17.86 Cr
Qtr End: Dec 25
NAV
₹16.951
as of 17/04/2026
3Y Returns (CAGR)
20.53%
Expense Ratio
0.47%
as of 01/03/2026
AUM
₹17.86 Cr
Qtr End: Dec 25
NAV
₹16.951
as of 17/04/2026
Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
| Period | Returns | CAGR | Volatility |
|---|---|---|---|
| 3M | 2.41% | 9.99% | 17.88% |
| 6M | -5.58% | -10.84% | 14.38% |
| 1Y | -1.98% | -1.98% | 13.52% |
| 3Y | 75.11% | 20.53% | 14.06% |
| 5Y | N/A | N/A | N/A |
Scheme Details
- Launch Date
- 18/10/2021
- Fund Age
- 4.5 years
- Minimum Investment
- ₹5,000
- Fund House
- ITI Mutual Fund
- Category
- Equity Scheme
- Sub-category
- Sectoral/ Thematic (Equity Scheme)
Similar Funds
Top funds in the same category and sub-category.
| Scheme | 3Y CAGR (%) | TER (%) | AUM (Cr) |
|---|---|---|---|
| Aditya Birla Sun Life International Equity Fund - Direct - Growth | 19.01% | 2.06% | ₹69.63 |
| DSP Banking & Financial Services Fund - Direct - Growth | - | 0.61% | ₹280.2 |
| SBI BANKING & FINANCIAL SERVICES FUND - Direct - Growth | 19.65% | 0.88% | ₹4,503.48 |
| HDFC Defence Fund - Direct - Growth | - | 0.82% | ₹1,912.49 |
| Mirae Asset Banking and Financial Services Fund - Direct - Growth | 17.17% | 0.63% | ₹344.25 |
| ITI Banking and Financial Services Fund - Direct - Growth | 14.54% | 0.40% | ₹10.21 |
| Tata Banking & Financial Services Fund - Direct - Growth | 16.42% | 0.51% | ₹899.75 |